Skip to main content
. Author manuscript; available in PMC: 2016 Feb 29.
Published in final edited form as: J Neurogenet. 2015 Jul 13;29(0):124–134. doi: 10.3109/01677063.2015.1050097

Figure 2.

Figure 2

The sloΔ55b mutation affects basal expression from the muscle/tracheal cell promoter but does not affect basal expression from the neural promoters of slo. Relative slo expression levels in wild-type and sloΔ55b stocks determined by real-time RT-PCR using either C1 primers that detect transcripts from both neural promoters (Panel A) or C2 primers that detect transcripts from the muscle/tracheal cell promoter (Panel B). A) Basal expression of neural promoter specific transcripts is not altered by the sloΔ55b mutation. B) Basal expression from muscle/tracheal-specific promoter is altered by the sloΔ55b mutation. Transcript abundance is expressed relative to the wild type. Statistical significance was determined by Student’s t test (n = 3, *P ≤ 0.05). Error bars represent SEM.